FDA-Approved Cancer Drugs Offer New Hope in Halting Parkinson’s Disease Progression
Synopsis : The spread of harmful alpha-synuclein proteins in Parkinson’s disease was found to be caused by the Aplp1 protein, according to the researchers. In particular, a cancer medication that has received FDA approval has a significant impact by specifically targeting the protein Lag3 and preventing its interaction with Aplp1, which stops the disease from […]
FDA-Approved Cancer Drugs Offer New Hope in Halting Parkinson’s Disease Progression Read More »